Ran Nussbaum is a director of Keros Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Keros Therapeutics, Inc.
8 Jun 23
4/A
UroGen Pharma Ltd.
28 Feb 23
4/A
UroGen Pharma Ltd.
28 Feb 23
4
UroGen Pharma Ltd.
28 Feb 23
4
Keros Therapeutics, Inc.
30 Nov 22
3/A
Keros Therapeutics, Inc.
30 Nov 22
4
UroGen Pharma Ltd.
25 Oct 22
4
UroGen Pharma Ltd.
25 Aug 22
4
Eloxx Pharmaceuticals, Inc.
17 Jun 22
4
UroGen Pharma Ltd.
10 Jun 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
6 Jun 23 | KROS Keros Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 48.79 | 10,000 | 487.90 k | 10,000 |
29 Nov 22 | KROS Keros Therapeutics | Common Stock | Dispose X | Yes | No | 0.0001 | 1,914 | 0.19 | 1,226,412 | |
29 Nov 22 | KROS Keros Therapeutics | Common Stock | Dispose X | Yes | No | 0.0001 | 1,723 | 0.17 | 1,121,045 | |
29 Nov 22 | KROS Keros Therapeutics | Common Stock | Dispose X | Yes | No | 0.0001 | 3,539 | 0.35 | 2,284,612 | |
29 Nov 22 | KROS Keros Therapeutics | Call Options (obligation to sell) Common Stock | Dispose X | Yes | No | 0.0001 | 1,914 | 0.19 | 0 | |
29 Nov 22 | KROS Keros Therapeutics | Call Options (obligation to sell) Common Stock | Dispose X | Yes | No | 0.0001 | 1,723 | 0.17 | 0 | |
29 Nov 22 | KROS Keros Therapeutics | Call Options (obligation to sell) Common Stock | Dispose X | Yes | No | 0.0001 | 3,539 | 0.35 | 0 |